vs

Side-by-side financial comparison of Assertio Holdings, Inc. (ASRT) and Rumble Inc. (RUM). Click either name above to swap in a different company.

Rumble Inc. is the larger business by last-quarter revenue ($27.1M vs $13.5M, roughly 2.0× Assertio Holdings, Inc.). On growth, Rumble Inc. posted the faster year-over-year revenue change (-10.5% vs -57.9%). Over the past eight quarters, Rumble Inc.'s revenue compounded faster (15.2% CAGR vs -35.4%).

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As o...

Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".

ASRT vs RUM — Head-to-Head

Bigger by revenue
RUM
RUM
2.0× larger
RUM
$27.1M
$13.5M
ASRT
Growing faster (revenue YoY)
RUM
RUM
+47.5% gap
RUM
-10.5%
-57.9%
ASRT
Faster 2-yr revenue CAGR
RUM
RUM
Annualised
RUM
15.2%
-35.4%
ASRT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASRT
ASRT
RUM
RUM
Revenue
$13.5M
$27.1M
Net Profit
$-32.7M
Gross Margin
5.5%
Operating Margin
-86.7%
-131.1%
Net Margin
-120.8%
Revenue YoY
-57.9%
-10.5%
Net Profit YoY
86.2%
EPS (diluted)
$-4.54
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASRT
ASRT
RUM
RUM
Q4 25
$13.5M
$27.1M
Q3 25
$49.5M
$24.8M
Q2 25
$29.2M
Q1 25
$26.5M
$23.7M
Q4 24
$32.2M
$30.2M
Q3 24
$29.2M
$25.1M
Q2 24
$31.1M
$22.5M
Q1 24
$32.4M
$17.7M
Net Profit
ASRT
ASRT
RUM
RUM
Q4 25
$-32.7M
Q3 25
$11.4M
$-16.3M
Q2 25
$-16.4M
Q1 25
$-13.5M
$-2.7M
Q4 24
$-236.8M
Q3 24
$-2.9M
$-31.5M
Q2 24
$-3.7M
$-26.8M
Q1 24
$-4.5M
$-43.3M
Gross Margin
ASRT
ASRT
RUM
RUM
Q4 25
5.5%
Q3 25
-1.8%
Q2 25
Q1 25
-26.7%
Q4 24
-14.2%
Q3 24
-45.4%
Q2 24
-58.8%
Q1 24
-79.5%
Operating Margin
ASRT
ASRT
RUM
RUM
Q4 25
-86.7%
-131.1%
Q3 25
23.2%
-113.6%
Q2 25
-27.5%
Q1 25
-50.0%
-153.5%
Q4 24
-41.9%
-80.1%
Q3 24
-10.4%
-131.0%
Q2 24
-11.6%
-172.7%
Q1 24
-13.4%
-197.4%
Net Margin
ASRT
ASRT
RUM
RUM
Q4 25
-120.8%
Q3 25
23.1%
-65.7%
Q2 25
-56.0%
Q1 25
-51.1%
-11.2%
Q4 24
-783.2%
Q3 24
-10.0%
-125.9%
Q2 24
-11.8%
-119.2%
Q1 24
-13.9%
-244.1%
EPS (diluted)
ASRT
ASRT
RUM
RUM
Q4 25
$-4.54
$-0.13
Q3 25
$0.11
$-0.06
Q2 25
$-0.17
Q1 25
$-0.14
$-0.01
Q4 24
$-3.28
$-1.17
Q3 24
$-0.03
$-0.15
Q2 24
$-0.04
$-0.13
Q1 24
$-0.05
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASRT
ASRT
RUM
RUM
Cash + ST InvestmentsLiquidity on hand
$63.4M
$237.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$94.0M
$274.8M
Total Assets
$267.0M
$336.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASRT
ASRT
RUM
RUM
Q4 25
$63.4M
$237.9M
Q3 25
$93.4M
$269.8M
Q2 25
$98.2M
Q1 25
$87.3M
$301.3M
Q4 24
$100.1M
$114.0M
Q3 24
$88.6M
$132.0M
Q2 24
$88.4M
$154.2M
Q1 24
$80.7M
$183.8M
Total Debt
ASRT
ASRT
RUM
RUM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$38.6M
Stockholders' Equity
ASRT
ASRT
RUM
RUM
Q4 25
$94.0M
$274.8M
Q3 25
$105.8M
$302.2M
Q2 25
$93.3M
Q1 25
$108.5M
$339.6M
Q4 24
$121.1M
$-63.1M
Q3 24
$130.5M
$166.1M
Q2 24
$132.2M
$192.7M
Q1 24
$134.5M
$210.7M
Total Assets
ASRT
ASRT
RUM
RUM
Q4 25
$267.0M
$336.8M
Q3 25
$319.8M
$367.2M
Q2 25
$273.8M
Q1 25
$286.4M
$391.1M
Q4 24
$284.7M
$195.3M
Q3 24
$276.0M
$217.2M
Q2 24
$279.4M
$243.2M
Q1 24
$282.0M
$263.0M
Debt / Equity
ASRT
ASRT
RUM
RUM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASRT
ASRT
RUM
RUM
Operating Cash FlowLast quarter
$-30.0M
$-29.4M
Free Cash FlowOCF − Capex
$-31.7M
FCF MarginFCF / Revenue
-117.2%
Capex IntensityCapex / Revenue
8.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASRT
ASRT
RUM
RUM
Q4 25
$-30.0M
$-29.4M
Q3 25
$-4.8M
$-10.6M
Q2 25
$19.1M
Q1 25
$-12.5M
$-14.5M
Q4 24
$11.5M
$-12.4M
Q3 24
$-35.0K
$-19.1M
Q2 24
$7.4M
$-21.7M
Q1 24
$7.5M
$-33.9M
Free Cash Flow
ASRT
ASRT
RUM
RUM
Q4 25
$-31.7M
Q3 25
$-12.0M
Q2 25
Q1 25
$-14.6M
Q4 24
$-12.4M
Q3 24
$-19.9M
Q2 24
$-23.1M
Q1 24
$-34.3M
FCF Margin
ASRT
ASRT
RUM
RUM
Q4 25
-117.2%
Q3 25
-48.6%
Q2 25
Q1 25
-61.7%
Q4 24
-40.9%
Q3 24
-79.5%
Q2 24
-102.8%
Q1 24
-193.3%
Capex Intensity
ASRT
ASRT
RUM
RUM
Q4 25
8.5%
Q3 25
5.7%
Q2 25
Q1 25
0.6%
Q4 24
0.1%
Q3 24
0.0%
3.4%
Q2 24
6.1%
Q1 24
2.4%
Cash Conversion
ASRT
ASRT
RUM
RUM
Q4 25
Q3 25
-0.42×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASRT
ASRT

Products$12.8M95%
Other$719.0K5%

RUM
RUM

Audience Monetization$23.8M88%
Other Initiatives$3.3M12%

Related Comparisons